282 related articles for article (PubMed ID: 20202764)
1. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome.
Osterrieder N; Van de Walle GR
Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764
[TBL] [Abstract][Full Text] [Related]
2. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
3. Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance.
van der Meulen KM; Favoreel HW; Pensaert MB; Nauwynck HJ
Vet Immunol Immunopathol; 2006 May; 111(1-2):31-40. PubMed ID: 16472872
[TBL] [Abstract][Full Text] [Related]
4. Equine alphaherpesviruses (EHV-1 and EHV-4) differ in their efficiency to infect mononuclear cells during early steps of infection in nasal mucosal explants.
Vandekerckhove AP; Glorieux S; Gryspeerdt AC; Steukers L; Van Doorsselaere J; Osterrieder N; Van de Walle GR; Nauwynck HJ
Vet Microbiol; 2011 Aug; 152(1-2):21-8. PubMed ID: 21536394
[TBL] [Abstract][Full Text] [Related]
5. Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression.
Wimer CL; Damiani A; Osterrieder N; Wagner B
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):266-74. PubMed ID: 21349590
[TBL] [Abstract][Full Text] [Related]
6. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains.
Wagner B; Wimer C; Freer H; Osterrieder N; Erb HN
Vet Immunol Immunopathol; 2011 Sep; 143(1-2):116-24. PubMed ID: 21764140
[TBL] [Abstract][Full Text] [Related]
7. The role of secreted glycoprotein G of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in immune modulation and virulence.
Thormann N; Van de Walle GR; Azab W; Osterrieder N
Virus Res; 2012 Oct; 169(1):203-11. PubMed ID: 22902480
[TBL] [Abstract][Full Text] [Related]
8. Temporal detection of equine herpesvirus infections of a cohort of mares and their foals.
Bell SA; Balasuriya UB; Gardner IA; Barry PA; Wilson WD; Ferraro GL; MacLachlan NJ
Vet Microbiol; 2006 Sep; 116(4):249-57. PubMed ID: 16774810
[TBL] [Abstract][Full Text] [Related]
9. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
10. Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)--masters of co-evolution and a constant threat to equids and beyond.
Ma G; Azab W; Osterrieder N
Vet Microbiol; 2013 Nov; 167(1-2):123-34. PubMed ID: 23890672
[TBL] [Abstract][Full Text] [Related]
11. Expression of late viral proteins is restricted in nasal mucosal leucocytes but not in epithelial cells during early-stage equine herpes virus-1 infection.
Gryspeerdt AC; Vandekerckhove AP; Baghi HB; Van de Walle GR; Nauwynck HJ
Vet J; 2012 Aug; 193(2):576-8. PubMed ID: 22425309
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG).
von Einem J; Smith PM; Van de Walle GR; O'Callaghan DJ; Osterrieder N
Virology; 2007 May; 362(1):151-62. PubMed ID: 17250864
[TBL] [Abstract][Full Text] [Related]
13. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
[TBL] [Abstract][Full Text] [Related]
14. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
15. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review.
Patel JR; Heldens J
Vet J; 2005 Jul; 170(1):14-23. PubMed ID: 15993786
[TBL] [Abstract][Full Text] [Related]
16. The C-terminal regions of the envelope glycoprotein gp2 of equine herpesviruses 1 and 4 are antigenically distinct.
Learmonth GS; Love DN; Wellington JE; Gilkerson JR; Whalley JM
Arch Virol; 2002 Mar; 147(3):607-15. PubMed ID: 11958459
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
Platt R; Sponseller BA; Chiang YW; Roth JA
Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
[TBL] [Abstract][Full Text] [Related]
18. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413
[TBL] [Abstract][Full Text] [Related]
19. Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia.
van der Meulen K; Caij B; Pensaert M; Nauwynck H
Vet Microbiol; 2006 Mar; 113(3-4):265-73. PubMed ID: 16387454
[TBL] [Abstract][Full Text] [Related]
20. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
